FOGHORN THERAPEUTICS INC's ticker is FHTX and the CUSIP is 344174107. A total of 62 filers reported holding FOGHORN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $79,755 | -25.6% | 15,951 | +4.8% | 0.00% | – |
| Q2 2023 | $107,128 | -44.4% | 15,217 | -51.0% | 0.00% | – |
| Q1 2023 | $192,665 | -10.9% | 31,075 | -8.3% | 0.00% | – |
| Q4 2022 | $216,174 | +49.1% | 33,883 | +100.2% | 0.00% | – |
| Q3 2022 | $145,000 | -35.0% | 16,922 | +3.3% | 0.00% | – |
| Q2 2022 | $223,000 | +11.5% | 16,378 | +24.6% | 0.00% | – |
| Q1 2022 | $200,000 | -76.0% | 13,145 | -63.9% | 0.00% | – |
| Q4 2021 | $833,000 | +368.0% | 36,443 | +184.5% | 0.00% | – |
| Q3 2021 | $178,000 | -19.1% | 12,809 | +18.1% | 0.00% | – |
| Q4 2020 | $220,000 | – | 10,845 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Capital LLC | 1,261,261 | $13,458,000 | 4.37% |
| Birchview Capital, LP | 314,143 | $3,352,000 | 2.00% |
| Flagship Pioneering Inc. | 12,674,120 | $135,233,000 | 1.73% |
| Monashee Investment Management LLC | 530,581 | $5,661,000 | 0.68% |
| Artal Group S.A. | 1,720,720 | $18,360,000 | 0.37% |
| Alphabet Inc. | 500,901 | $5,345,000 | 0.11% |
| Casdin Capital, LLC | 216,216 | $2,307,000 | 0.06% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 84,000 | $896,000 | 0.01% |
| NewSquare Capital LLC | 5,000 | $53,000 | 0.01% |
| FMR LLC | 2,540,434 | $27,106,000 | 0.00% |